Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up

A 59-year-old male with a history of hepatitis C cirrhosis and history of hepatitis B exposure presented 8 months after orthotopic liver transplant (LT) with fever, fatigue, myalgia, night sweats, nonproductive cough, and shortness of breath. Bone marrow biopsy for pancytopenia was positive for Epst...

Full description

Bibliographic Details
Main Authors: Lokesh K. Jha, Laura L. Ulmer, Marco A. Olivera-Martinez, Timothy M. McCashland, Kai Fu, Fedja A. Rochling
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Case Reports in Hepatology
Online Access:http://dx.doi.org/10.1155/2018/9324872
id doaj-cde140e0f09d49379fda6bfb6155466c
record_format Article
spelling doaj-cde140e0f09d49379fda6bfb6155466c2020-11-24T20:47:27ZengHindawi LimitedCase Reports in Hepatology2090-65872090-65952018-01-01201810.1155/2018/93248729324872Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-UpLokesh K. Jha0Laura L. Ulmer1Marco A. Olivera-Martinez2Timothy M. McCashland3Kai Fu4Fedja A. Rochling5Division of Gastroenterology & Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USADivision of Gastroenterology & Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USADivision of Gastroenterology & Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USADivision of Gastroenterology & Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USADepartment of Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE, USADivision of Gastroenterology & Hepatology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USAA 59-year-old male with a history of hepatitis C cirrhosis and history of hepatitis B exposure presented 8 months after orthotopic liver transplant (LT) with fever, fatigue, myalgia, night sweats, nonproductive cough, and shortness of breath. Bone marrow biopsy for pancytopenia was positive for Epstein-Barr virus (EBV) DNA. Lymph node biopsy for lymphadenopathy on imaging showed human herpes virus 8 (HHV8) associated Castleman’s disease. Treatment included valganciclovir, rituximab, and prednisone taper with eventual discontinuation. Quantitative HHV8 DNA was initially 611,000 DNA copies/mL and was later undetectable at 6 months following treatment and remained undetectable at 3-year follow-up.http://dx.doi.org/10.1155/2018/9324872
collection DOAJ
language English
format Article
sources DOAJ
author Lokesh K. Jha
Laura L. Ulmer
Marco A. Olivera-Martinez
Timothy M. McCashland
Kai Fu
Fedja A. Rochling
spellingShingle Lokesh K. Jha
Laura L. Ulmer
Marco A. Olivera-Martinez
Timothy M. McCashland
Kai Fu
Fedja A. Rochling
Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
Case Reports in Hepatology
author_facet Lokesh K. Jha
Laura L. Ulmer
Marco A. Olivera-Martinez
Timothy M. McCashland
Kai Fu
Fedja A. Rochling
author_sort Lokesh K. Jha
title Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
title_short Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
title_full Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
title_fullStr Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
title_full_unstemmed Castleman’s Disease and Posttransplant Lymphoproliferative Disorder after Liver Transplant: 3-Year Follow-Up
title_sort castleman’s disease and posttransplant lymphoproliferative disorder after liver transplant: 3-year follow-up
publisher Hindawi Limited
series Case Reports in Hepatology
issn 2090-6587
2090-6595
publishDate 2018-01-01
description A 59-year-old male with a history of hepatitis C cirrhosis and history of hepatitis B exposure presented 8 months after orthotopic liver transplant (LT) with fever, fatigue, myalgia, night sweats, nonproductive cough, and shortness of breath. Bone marrow biopsy for pancytopenia was positive for Epstein-Barr virus (EBV) DNA. Lymph node biopsy for lymphadenopathy on imaging showed human herpes virus 8 (HHV8) associated Castleman’s disease. Treatment included valganciclovir, rituximab, and prednisone taper with eventual discontinuation. Quantitative HHV8 DNA was initially 611,000 DNA copies/mL and was later undetectable at 6 months following treatment and remained undetectable at 3-year follow-up.
url http://dx.doi.org/10.1155/2018/9324872
work_keys_str_mv AT lokeshkjha castlemansdiseaseandposttransplantlymphoproliferativedisorderafterlivertransplant3yearfollowup
AT lauralulmer castlemansdiseaseandposttransplantlymphoproliferativedisorderafterlivertransplant3yearfollowup
AT marcoaoliveramartinez castlemansdiseaseandposttransplantlymphoproliferativedisorderafterlivertransplant3yearfollowup
AT timothymmccashland castlemansdiseaseandposttransplantlymphoproliferativedisorderafterlivertransplant3yearfollowup
AT kaifu castlemansdiseaseandposttransplantlymphoproliferativedisorderafterlivertransplant3yearfollowup
AT fedjaarochling castlemansdiseaseandposttransplantlymphoproliferativedisorderafterlivertransplant3yearfollowup
_version_ 1716809952782188544